The company is focused on expanding its healthcare solution portfolio to offer painless blood collection options for at-home diagnostic testing. Credit: National Cancer Institute on Unsplash.

Thorne HealthTech has received a CE mark certification for its at-home blood-sampling device, NanoDrop.

The clinical-grade device leverages the company’s new dual nano lancet technology to collect capillary whole-blood samples.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

This technology is already incorporated into the company’s OneDraw blood collection system.

The CE mark approval will now enable individuals to use the device for new testing applications at their homes.

Thorne HealthTech CEO Paul Jacobson said: “We consistently continue to find ways to improve the blood draw experience and with the dual nano lancet technology being a key part of the blood collection process, we look forward to making NanoDrop available across the European Union, which will allow more customers to experience and benefit from it.

“We believe this incremental news, combined with prior OneDraw clearance in Japan, puts Thorne one step closer to achieving broad application across end-markets around the globe.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company is focused on expanding its healthcare solution portfolio to offer painless blood collection options for at-home diagnostic testing and decentralised clinical trials.

Last month, Thorne announced the signing of a research and development partnership agreement with Arome Science to develop a new metabolomics test.

The companies agreed to work together to develop a commercial metabolomics wellness tes which will assist research studies by using the OneDraw device for at-home blood collection.

Thorne is claimed to be the only supplement manufacturer that works with Mayo Clinic on health and wellness research and content.